Histopathological changes and inflammatory and cell death pathways in the lungs of Balb/c mice with pneumonia induced by different concentrations of Staphylococcus aureus
- 대한해부학회
- Anatomy and Cell Biology
- Vol.58(3)
-
2025.09444 - 459 (16 pages)
-
DOI : 10.5115/acb.24.304
- 0
Pneumonia is often triggered by a bacterial infection, in many cases Staphylococcus aureus. Although thisbacterium is found in the microbiota of healthy individuals, it can proliferate and release toxins in the respiratory tract,causing tissue damage by activating the inflammatory process and cell death pathways and resulting in serious complications. In this study, pneumonia was induced in Balb/c mice using different concentrations of S. aureus to evaluate histopathologicalchanges and progression with increasing concentrations of colony forming units (CFUs) as well as their interactions withinflammatory and cell death markers. Hematoxylin and eosin histological techniques and peroxidase immunohistochemistrywere utilized to investigate outcomes that included edema and disruption of the bronchiole and blood vessel walls. Alveolarcollapse and bronchiolar hyperplasia were also analyzed and were statistically significant, but only hyperplasia variedbetween the two groups that received intermediate concentrations of CFU (107 and 108, respectively) to induce pneumonia. Inthe immunohistochemical analysis, progression of apoptosis was observed in groups that received up to 108 CFU, along witha probable predominance of autophagy and reduction in IL-6 in the group that received the highest concentration (109 CFU). These characteristics appear to indicate an attempt to preserve and reuse cells when high CFU concentrations are presentand eliminate infected cells at lower concentrations. The data from this present study contribute to understanding crosstalkbetween cell death pathways and the inflammatory response in S. aureus-induced pneumonia, and may assist in futureintervention strategies.
Introduction
Materials and Methods
Results
Discussion
ORCID
Author Contributions
Conflicts of Interest
Funding
Acknowledgements
References
(0)
(0)